How Davis was paid
$1.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Robert LisickiFormer Chief Executive Officer | $624,000 | — | $1,118,295 | — | $1,742,295 |
| Kim DavisChief Operating Officer, Chief Legal Officer and Interim Chief Executive Officer | $486,359 | $312,000 | $474,087 | $8,844 | $1,281,291 |
| Eric HyllengrenFormer Chief Financial Officer | $230,303 | $95,000 | $711,312 | $11,875 | $1,048,490 |
| Kiran NistalaChief Medical Officer and Head of Development | $468,334 | $213,405 | $331,415 | $9,414 | $1,022,568 |
What changed and why
- $1.28M$1.28M: Kim Davis’s 2025 total compensation, down from $1.80M in 2024.
- $312K$312,000: Davis’s 2025 bonus, including $91,000 for interim CEO service.
- $1.12M$1.12M: Robert Lisicki’s 2025 option awards, despite receiving no 2025 bonus.
- $95,000$95,000: Eric Hyllengren’s prorated 2025 bonus after joining July 7.
- January 21, 2026: Lisicki resigned and Dr. Kulkarni became chief executive officer.
- Four-year vesting generally applied to executive stock options and RSUs.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.